Adicet Bio (ACET) Other Accumulated Expenses (2017 - 2026)

Adicet Bio's Other Accumulated Expenses history runs 10 years deep, the most recent figure standing at $169000.0 for Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 70.04% year-over-year to $169000.0; the TTM figure through Mar 2026 stood at $169000.0 (down 70.04% YoY), while the FY2025 annual figure was $367000.0, down 7.79% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $169000.0, down from $367000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $1.7 million in Q3 2024, with the low at $12000.0 in Q4 2023.
• The 5-year median for Other Accumulated Expenses is $181000.0 (2022), against an average of $317117.6.
• The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses surged 5335.48% in 2024, then slumped 96.1% in 2025.
• Adicet Bio's Other Accumulated Expenses stood at $31000.0 in 2022, then sank by 61.29% to $12000.0 in 2023, then jumped by 3216.67% to $398000.0 in 2024, then declined by 7.79% to $367000.0 in 2025, then slumped by 53.95% to $169000.0 in 2026.
• Business Quant data shows ACET's Other Accumulated Expenses at $169000.0 in Q1 2026, $367000.0 in Q4 2025, and $596000.0 in Q3 2025.